- Home
- NTIP vs UG Comparison
NTIP vs UG Comparison
Compare NTIP & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIP
- UG
- Stock Information
- Founded
- NTIP 1990
- UG 1942
- Country
- NTIP United States
- UG United States
- Employees
- NTIP N/A
- UG N/A
- Industry
- NTIP Multi-Sector Companies
- UG Package Goods/Cosmetics
- Sector
- NTIP Miscellaneous
- UG Consumer Discretionary
- Exchange
- NTIP Nasdaq
- UG Nasdaq
- Market Cap
- NTIP 31.9M
- UG 36.8M
- IPO Year
- NTIP 1998
- UG N/A
- Fundamental
- Price
- NTIP $1.21
- UG $8.06
- Analyst Decision
- NTIP
- UG
- Analyst Count
- NTIP 0
- UG 0
- Target Price
- NTIP N/A
- UG N/A
- AVG Volume (30 Days)
- NTIP 11.4K
- UG 12.6K
- Earning Date
- NTIP 05-16-2025
- UG 05-08-2025
- Dividend Yield
- NTIP 8.03%
- UG 8.70%
- EPS Growth
- NTIP N/A
- UG 4.82
- EPS
- NTIP N/A
- UG 0.63
- Revenue
- NTIP $100,000.00
- UG $11,408,154.00
- Revenue This Year
- NTIP N/A
- UG N/A
- Revenue Next Year
- NTIP N/A
- UG N/A
- P/E Ratio
- NTIP N/A
- UG $12.79
- Revenue Growth
- NTIP N/A
- UG N/A
- 52 Week Low
- NTIP $1.17
- UG $7.73
- 52 Week High
- NTIP $2.00
- UG $16.25
- Technical
- Relative Strength Index (RSI)
- NTIP 41.74
- UG 42.37
- Support Level
- NTIP $1.17
- UG $7.84
- Resistance Level
- NTIP $1.28
- UG $8.44
- Average True Range (ATR)
- NTIP 0.04
- UG 0.38
- MACD
- NTIP 0.00
- UG 0.04
- Stochastic Oscillator
- NTIP 33.33
- UG 24.52
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.